In the rapidly evolving healthcare landscape, the demand for efficient, reliable, and timely diagnostics is more critical than ever. Among the various sectors experiencing significant growth, the Point of Care (POC) Coagulation Testing Devices market stands out, projected to reach a valuation of USD 2.86 billion by 2032 from USD 1.65 billion in 2023. This growth, characterized by a Compound...